Time to really share real-world data?
Sophie GrahamLaura McDonaldRadek WasiakMichael LeesSreeram V RamagopalanPublished in: F1000Research (2018)
Data other than that from clinical trials are important for healthcare decision making. However, unlike the vocal calls seen for more open access to trial data, there are limited efforts being made to ensure that agencies that collect real-world data (RWD) share this, despite its importance. There are many RWD sources across the world that could be readily exploited for research once shared. There are policy and privacy questions that need to be tackled, but opening up and sharing RWD offers remarkable potential for improvements in care for individuals and more effective use of limited healthcare resources. Open science should become the standard for RWD as well as clinical trials, especially those that have a high likelihood to influence practice.
Keyphrases
- healthcare
- clinical trial
- big data
- electronic health record
- decision making
- public health
- minimally invasive
- health information
- phase ii
- primary care
- randomized controlled trial
- phase iii
- mental health
- palliative care
- study protocol
- drinking water
- pain management
- data analysis
- affordable care act
- artificial intelligence
- double blind